LY-355455

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameLY-355455

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionPeptide hydrolase inhibitors

TargetsPeptide hydrolase

Therapy Area/IndicationsRhinovirus infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEli Lilly And Company

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEli Lilly And Company

Active IndicationsN/A

Inactive IndicationsRhinovirus infection

Other Information

ATC CodeN/A

Related LinksN/A